AGP Wire

AGP

Türkiye will use the inaugural GITEX Ai Türkiye in Istanbul next month to highlight its plan to train 10,000 AI specialists, 100,000 application professionals and 5 million AI-literate citizens by 2028. The event will bring together global tech…

AGP

New research from NIQ and World Data Lab says age is no longer the best predictor of shopping behavior as consumers increasingly toggle between premium and value choices.

AGP

As Chinese automakers push deeper into overseas markets, winning on price and performance is no longer enough.

AGP

The Business Research Company says the ocular drug delivery market is on track to grow from $19.16 billion in 2025 to $29.44 billion by 2030, driven by aging populations, chronic eye disease and new delivery technologies.

AGP

The Business Research Company says the ocular trauma devices market will rise from $3.88 billion in 2025 to $4.17 billion in 2026, then reach $5.53 billion by 2030. Growth is tied to eye injuries, road accidents and wider access to emergency and…

AGP

The oral sleep apnea devices market is projected to grow from $1.46 billion in 2025 to $1.64 billion in 2026, with demand rising as sleep disorders become more common and patients look for non-invasive treatment options.

AGP

The Business Research Company says the ophthalmic eye dropper market will rise from $14.28 billion in 2025 to $15.39 billion in 2026, with growth continuing to $20.07 billion by 2030. Demand is being shaped by more eye disorders, wider use of…

AGP

The optometry equipment market is projected to grow from $3.79 billion in 2025 to $5.5 billion by 2030 as aging populations, vision disorders and AI-assisted diagnostics lift demand.

AGP

The Caribbean Tourism Organization will debut a new research forum during SOTIC 2026 in Guyana on Oct. 6, aiming to link academic work with tourism policy and industry action.

AGP

The Business Research Company says the ophthalmic medical lasers market will grow from $1.33 billion in 2025 to $1.89 billion by 2030, driven by aging populations, more laser-based eye procedures and AI-assisted guidance.

AGP

The operating-room instrument sterile robot market is projected to climb from $1.92 billion in 2025 to $2.18 billion in 2026, driven by rising hospital-acquired infections, more robotic-assisted surgery and higher demand for sterile, efficient…

AGP

The medical linear accelerator market is projected to grow from $4.35 billion in 2026 to $6 billion by 2030, driven by rising cancer cases, more precise radiotherapy tools and broader hospital investment.

AGP

The orthobiologics devices and equipment market is projected to grow from $5.99 billion in 2025 to $8.64 billion by 2030, driven by aging populations, musculoskeletal disorders and demand for minimally invasive orthopedic treatments.

AGP

The ophthalmic viscoelastic devices market is projected to grow from $2.72 billion in 2025 to $3.47 billion by 2030, driven by rising eye surgeries, aging populations and demand for safer procedures.

AGP

The oncology biomarkers market is projected to grow from $19.73 billion in 2026 to $33.63 billion by 2030, driven by personalized cancer treatment, liquid biopsy adoption and AI-led discovery.

AGP

The optical coherence tomography market is projected to grow from $2.1 billion in 2025 to $4.04 billion by 2030, driven by demand for early disease detection, AI-enabled imaging and broader use beyond ophthalmology.

AGP

The Business Research Company says the open surgery instruments market is on track to grow from $68.04 billion in 2025 to $90.57 billion by 2030, driven by more chronic disease, complex procedures and hospital upgrades.

AGP

The Business Research Company says the nuclear reactor market is set to grow from $29.42 billion in 2025 to $31.08 billion in 2026, then to $38.54 billion by 2030. The report points to energy transition efforts, next-generation reactor types and…

AGP

The nuclear imaging devices and equipment market is projected to grow from $4 billion in 2025 to $4.71 billion by 2030, according to The Business Research Company.

AGP

The medical needle-free injection market is projected to climb from $16.13 billion in 2025 to $29.21 billion by 2030, according to a new report from The Business Research Company.